Intuitive Machines Stock Skyrockets on Big NASA Contract
Shares of Intuitive Machines blasted off nearly 60% Wednesday, a day after the space travel support firm received a NASA contract worth up to $4.82 billion.
Applied Therapeutics Stock Soars As FDA Scraps Panel Meeting For Its Inherited Metabolic Disorder Drug
On Wednesday, Applied Therapeutics, Inc. (NASDAQ:APLT) stock traded higher with a session volume of 31.75 million, compared to an average volume of 1.26 million, according to data from Benzinga Pro. The company announced an update on the ongoing New Drug Application (NDA) review of govorestat for Classic Galactosemia. Galactosemia is an inherited metabolic disorder that makes the body unable to process a sugar called galactose. Also Read: Why Is Rare Disease-Focused Applied Therapeutics Stock Tr
Bank of America Takes a Bullish Stance on These 2 Stocks
The Federal Reserve’s FOMC committee will meet today, and with the pace of inflation down to an annualized rate of 2.5%, the conventional wisdom expects the central bank to start cutting rates. The Fed has held its key funds rate at the 5.25% to 5.50% range since July of last year, in response to a generational spike in inflation. Most Fed watchers are predicting that the bank’s governors will approve a cut of 25 basis points, or 0.25%. While modest, that would mark the end of a 14-month tight m
Hedge Funds Shun the Brazil Trade Winning Fans in Wall Street
(Bloomberg) -- Some of Wall Street’s biggest banks are telling clients to place bullish bets on Brazil, calling an end to the malaise that has plagued local markets this year.Most Read from BloombergCalifornia’s Anti-Speeding Bill Can Be a Traffic Safety BreakthroughPipe Fire Near Houston Forces Residents to EvacuateTo Build a Happier City, Design for DensityLondon Mayor Plans to Pedestrianize Busy Oxford StreetNew York City’s Transit System Plans $65.4 Billion of Upgrades for Grand Central, Sub
Tencent looks overseas as Chinese tech market nears maturity
Regions highlighted as key expansion areas are South-East Asia ex-China, and the Middle East and Africa.
Vivos Therapeutics Says It Is Poised To Disrupt Pediatric Sleep Apnea Market, Secures FDA Approval For DNA Appliance To Treat Snoring In Children
On Wednesday, the FDA granted 510(k) clearance to Vivos Therapeutics, Inc.’s (NASDAQ:VVOS) flagship oral medical device, which is used to treat moderate to severe obstructive sleep apnea (OSA) and snoring in children. Recent published studies report up to 10.1 million U.S. children (ages 6-17) are estimated to suffer from pediatric OSA. Vivos’ DNA appliance is non-invasive, safe, comfortable, affordable, and highly effective. It is designed to reduce nighttime snoring and treat moderate to sever
Nvidia, ARM initiated: Wall Street's top analyst calls
Nvidia, ARM initiated: Wall Street's top analyst calls
OnTop partners with dLocal across 27 global high-growth markets
Strategic alliance will streamline currency conversion and improve payment efficiency in emerging markets
Watch These GE Vernova Price Levels as Stock Trading Near Record High
GE Vernova shares will likely remain on watchlists Wednesday after hitting a new record high yesterday following favorable coverage from leading investment banks. Monitor these important chart levels.
How the Fed’s rate decision could unravel a big bond-market recession bet
The stakes for investors are running high ahead of a historic rate cut expected from the Federal Reserve on Wednesday.